Sensome today announced proof-of-concept cases using its Clotild smart guidewire system with robotic thrombectomy technology. The company said the cases using Clotild were performed with commercial and next-generation robotic systems from Robocath. This effort demonstrated the feasibility of Paris-based Sensome's smart guidewire technology with … [Read more...] about Sensome reports positive proof-of-concept outcomes in robotic thrombectomy
